Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.
Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved ...
FDA approves Vertex’s acute pain treatment Journavx
The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...
FDA green lights new painkiller
The new drug type targets pathways in the peripheral nervous system before pain signals reach the brain, potentially lowering ...
WFMJ4m
FDA approves non-opioid pain medication
The Food and Drug Administration on Tuesday approved Journavx, the first drug in a new class of non-opioid pain medications, ...
Le Lézard25m
Elevating Connected Automotive Solutions with Cavli's AQ20 Autograde Module
Cavli Wireless, a leading innovator in IoT solutions, proudly announces the launch of its latest Autograde AQ20 IoT Module. The AQ20 is engineered to meet the rigorous demands of connected vehicle ...